M. Ravaioli, M.D., PhD

Similar documents
*6816* 6816 CONSENT FOR DECEASED KIDNEY DONOR ORGAN OPTIONS

Wake Forest School of Medicine Department of General Surgery

Kidney and Pancreas Transplant Evaluation Clinics and Committee: Inpatient Nephrology Transplant Consult Service

Where Will my New Kidney Come From?

Saint Francis Kidney Transplant Program Issue Date: 6/9/15

The New Kidney Allocation System: Resources for Protocols and Processes webinar.

Thoracoabdominal aortic aneurysm

Overview of Organ Donation and Transplantation

Living Donor Paired Exchange Registry. What is Living Kidney Donor Paired Exchange?

Transplant Coordinator

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

What is a Living Will?

renal transplantation: A single-center comparative study

Is a Kidney Transplant Right for Me?

Catheter insertion of a new aortic valve to treat aortic stenosis

David Axelrod, MD, MBA Associate Professor of Surgery Section Chief Solid Organ Transplantation Dartmouth Hitchcock Medical Center

How does a kidney transplant differ from dialysis?

Organ and Tissue Donation: An Overview

A PATIENT S GUIDE TO ABLATION THERAPY

ELSO GUIDELINES FOR ECMO CENTERS

Kidneys. Kidney Failure4. Transplantation

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

14.0 Stem Cell Laboratory Services

Bridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS

MAKING DOLLAR$ AND $ENSE

Children's Medical Services (CMS) Regional Perinatal Intensive Care Center (RPICC) Neonatal Extracorporeal Life Support (ECLS) Centers Questionnaire

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE

PANCREAS, PANCREAS-KIDNEY, SEGMENT OF PANCREAS AND ISLET PANCREATIC TISSUE TRANSPLANTATION SUR

Kidney Transplantation

FAQ. The Kidney Project

The State of the Liver in the Adult Patient after Fontan Palliation

Heart transplantation

Is a kidney transplant right for me?

INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY (IPHC) FOR PERITONEAL CARCINOMATOSIS AND MALIGNANT ASCITES. INFORMATION FOR PATIENTS AND FAMILY MEMBERS

THE BENEFITS OF LIVING DONOR KIDNEY TRANSPLANTATION. feel better knowing

ATTACHMENT I TO APPENDIX B OF UNOS BYLAWS

Blood Transfusion. Red Blood Cells White Blood Cells Platelets

LIVING KIDNEY DONATION

CONSENT FORM. Procedure: Descemet s Stripping Automated Endothelial Keratoplasty (DSAEK)

Introduction. Evaluation

Clinical Practice Assessment Robotic surgery

Introduction to Blood Management

KIDNEY PRE-TRANSPLANT EDUCATION BOOK

Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto

Preparing for ABO Determination, Reporting and Verification Policy Changes Webinar Script

David Axelrod, MD, MBA. Associate Professor of Surgery Section Chief- Solid Organ Transplantation Dartmouth- Hitchcock Medical Center

Resection, Reduction, and Revision of Aneurysmal AV Fistulas

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care

Kensington Eye Center 4701 Randolph Road, #G-2 Rockville, MD (301)

Questions and Answers for Transplant Candidates about the New Kidney Allocation System

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Understanding Treatment Options for Renal Therapy

Integrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases

Permanent Critical Illness Insurance

ADVANCE DIRECTIVE. Your Right to Make Health Care Decisions

Candidates about Multiple Listing and Waiting Time Transfer

Department of Surgery

Term Critical Illness Insurance

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Learning about Hepatitis C and Chronic Kidney Disease

INTRODUCTION. Chapter One

CURRICULUM VITAE. Alfonso Barnard Barragan, M.D. Suite 305 Monterey Park, CA (626)

Fireground Rehab Evaluation (FIRE) Trial

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

NATCO Introductory Education Course Objectives

Where World-Class Expertise and Genuine Compassion Come Together. AT THE FOREFRONT OF TRANSPLANT CARE Kidney Combined Kidney-Pancreas Pancreas Islets

Demystifying Transplant Performance Reviews. Robyn Zernhelt Performance Analyst

Donating Life. The Workplace Partnership for Life Program

Advanced Heart Failure & Transplantation Fellowship Program

Your Guide to Express Critical Illness Insurance Definitions

My Voice. Advance Care Plan

ANESTHESIA FOR MYOCARDIAL REVASCULARIZATION. Alla Klimova, M.D UAMS, Little Rock, AR

Heart Center Packages

CURRICULUM VITÆ. Prof. FRANCESCO DONATELLI

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden

Transcription:

Quale è il futuro dei trapianti di organo solido? Con la bioingegneria e l utilizzo di cellule staminali potremo curare meglio le insufficienze d organo e di tessuto? M. Ravaioli, M.D., PhD Department of General Surgery and Transplantation Prof. AD Pinna Policlinico Sant Orsola Malpighi University of Bologna, Italy

Il fegato artificiale impiantabile? By-pass but not liver available to transplantation Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet 1979 R.Y. Calne Venous Bypass in Clinical Liver Transplantation B.W. Shaw Ann Surg 1984

Il fegato artificiale impiantabile?

European gap among donors and recipients Extended criteria donors Living donors Candidates to Liver or Kidney Tx Split NHBD Deceased donors available Domino Effective allocation system

Extended criteria liver = Artificial liver?

Extended criteria donors Graft with an increased risk of early failure or inferior graft and patient survival resulting from per-transplant factors Extended Criteria Donor/Graft = ECD

MELD era, ECD and

Balance among: MELD era, ECD and Marginal graft MELD Recipient Selective criteria MELD era Pre-MELD era Quality transplant programs

Liver transplantation strategies from Kidney experience 1-3 hours Liver biopsy Expert pathologists on liver disease available 24 hours per day at our hospital Donor aorta clamped Recipient on the operating room Decision to accept the liver: senior surgeons considers the histological assessment and the macroscopic aspect as depicted by the harvesting surgeon 30 minutes Histo-pathological report by telephone

Liver transplantation strategies from Kidney experience Dissection Hepatectomy Transplantation Increased graft ischemia

Liver transplantation strategies from Kidney experience Dissection Hepatectomy Transplantation Short graft ischemia

Liver transplantation strategies from Kidney experience Ravaioli et al.transplant International 2009

Surgical Techniques To-day and To-morrow How to improve outcome of E.C.D. different form partial grafts?

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome? Transplantation of high-risk donor lungs that were physiologically stable during 4 hours of ex vivo perfusion led to results similar to those obtained with conventionally selected lungs

ECD, other strategies to improve the outcome? Static Ice System Simple, reproducible technique Inexpensive Few supply needs Little technical expertise needed Allows for easy long distance transportation Acceptable immediate function rates with short ischemic times Pulsatile Perfusion More complicated to set up More expensive Need machine, perfusion cassette and liquid especially design Technical expertise Provides a monitoring capability Allows transportation

ECD, other strategies to improve the outcome? Flow effects on the endothelial cell Kamm R, Annu. Rev. Fluid Mech. 2002 Endothelial cells under no-flow conditions (a) and after exposure to 1.2 Pa of steady, laminar shear stress for 24 h (b).

Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation

Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation

Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation DGF 70 pts machine-perfusion group vs. 89 cold-storage group (P = 0.01) One-year allograft survival was superior in the machine-perfusion group (94% vs. 90%, P = 0.04)

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome? Infusion fluids Organ chamber Venous Reservoir Membrane oxygenator Centrifugal Pump Urinometer Temperature probe

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome? The delayed graft function rate (DGF), defined as the requirement for dialysis within the first 7 days 1/18 (5.6%) EVNP group vs. 17/47 (36.2%) CS group p = 0.014 There was no difference in graft or patient survival at 12 months

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome? steatotic livers can be successfully preserved using normothermic preservation for prolonged periods and that normothermic preservation facilitates a reduction in hepatic steatosis

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome?

ECD, other strategies to improve the outcome? 20 LTs HMP preserved vs. 20 a matched group transplanted with CS livers Early allograft dysfunction Rates were 5%in the HMP group versus 25% in controls (p = 0.08)

ECD, other strategies to improve the outcome? Donors after cardiac death (DCD) maintain with normothermic extracorporeal membrane oxygenation (NECMO)

ECD, other strategies to improve the outcome?

ECD, other strategies Bologna researches..

ECD, other strategies Bologna researches..

ECD, other strategies Bologna researches..

ECD, other strategies Bologna researches..

ECD, other strategies Bologna researches.. T-0 T-1 T-2

Surgical Techniques To-day and To-morrow How will be future grafts?

Surgical Techniques To-day and To-morrow

Surgical Techniques To-day and To-morrow

Prospective fellows whom I trained in this field went on to pass on what we have learned to date from our research, not only as it applies to transplantation per se, but also to its broader implications for medicine as a whole

Conclusions: support donation and living donors